Detailed view for TVAG_362360

Basic information

TDR Targets ID: 889763
Trichomonas vaginalis, CMGC family protein kinase
Source Database / ID: 

pI: 9.1748 | Length (AA): 414 | MW (Da): 47955 | Paralog Number: 4

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG2

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0005524   ATP binding  
GO:0004672   protein kinase activity  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

No model available for this protein in Modbase.

PDB Structures:

No structure availble in the PDB for this protein

Expression

No expression data available for this gene

Orthologs

Ortholog group members (OG5_130162)

Species Accession Gene Product
Arabidopsis thaliana AT3G17750   protein kinase family protein
Arabidopsis thaliana AT1G73460   putative serine/threonine kinase
Arabidopsis thaliana AT1G73450   putative protein kinase
Arabidopsis thaliana AT2G40120   putative serine/threonine protein kinase
Babesia bovis BBOV_III009650   protein kinase domain containing protein
Cryptosporidium hominis Chro.70343   dual-specificity tyrosine-(Y)-phosphorylation regulated kinase TbPK4
Cryptosporidium parvum cgd7_3050   protein kinase
Giardia lamblia GL50803_17558   Kinase, CMGC DYRK
Giardia lamblia GL50803_137695   Kinase, CMGC DYRK
Leishmania braziliensis LbrM.14.1060   protein kinase, putative
Leishmania braziliensis LbrM.21.1940   protein kinase, putative
Leishmania donovani LdBPK_212010.1   protein kinase, putative
Leishmania donovani LdBPK_141140.1   protein kinase, putative
Leishmania infantum LinJ.14.1140   protein kinase, putative
Leishmania infantum LinJ.21.2010   protein kinase, putative
Leishmania major LmjF.21.1650   protein kinase, putative
Leishmania major LmjF.14.1070   protein kinase, putative
Leishmania mexicana LmxM.14.1070   protein kinase, putative
Leishmania mexicana LmxM.21.1650   protein kinase, putative
Neospora caninum NCLIV_020950   CMGC kinase, Dyrk family, putative
Oryza sativa 4327402   Os01g0832900
Oryza sativa 4333928   Os03g0719500
Oryza sativa 4339052   Os05g0466900
Trypanosoma brucei gambiense Tbg972.10.280   protein kinase, putative
Trypanosoma brucei gambiense Tbg972.7.4330   protein kinase, putative
Trypanosoma brucei Tb927.10.350   protein kinase PK4, putative
Trypanosoma brucei Tb927.7.3880   Basal body protein
Trypanosoma congolense TcIL3000_10_210   protein kinase, putative
Trypanosoma cruzi TcCLB.510519.40   protein kinase PK4, putative
Trypanosoma cruzi TcCLB.506869.60   protein kinase PK4, putative
Trypanosoma cruzi TcCLB.511249.60   CMGC/DYRK protein kinase, putative
Toxoplasma gondii TGME49_204280   cell-cycle-associated protein kinase DYRK, putative
Theileria parva TP04_0880   protein kinase, putative
Trichomonas vaginalis TVAG_000200   CMGC family protein kinase
Trichomonas vaginalis TVAG_396210   CMGC family protein kinase
Trichomonas vaginalis TVAG_048130   CMGC family protein kinase
Trichomonas vaginalis TVAG_238860   CMGC family protein kinase
Trichomonas vaginalis TVAG_362360   CMGC family protein kinase

Essentiality

TVAG_362360 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.7.3880 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.7.3880 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.7.3880 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.7.3880 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
Tb927.10.350 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.10.350 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb927.10.350 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.10.350 Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
TGME49_204280 Toxoplasma gondii Probably essential sidik
Show/Hide essentiality data references
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Rattus norvegicus Cell division protein kinase 5 292 aa 27.0% 307 aa Compounds References
Homo sapiens Cyclin-dependent kinase 1/cyclin B1 297 aa 26.8% 306 aa Compounds References
Sus scrofa Casein kinase I isoform alpha 125 aa 33.3% 126 aa Compounds References
Rattus norvegicus Mitogen-activated protein kinase 1 358 aa 27.9% 319 aa Compounds References
Plasmodium falciparum (isolate 3D7) Cell division control protein 2 homolog 288 aa 28.5% 305 aa Compounds References
Schizosaccharomyces pombe 972h- Casein kinase II subunit alpha 332 aa 25.6% 317 aa Compounds References
Rattus norvegicus MAP kinase p38 alpha 360 aa 28.2% 319 aa Compounds References
Obtained from network model

Ranking Plot

Putative Drugs List

Compound Raw Global Species
0.0012 0.5 0.5
0.0098 0.3242 0.2373
0.0059 1 1
0.0039 0.9485 0.5
0.0039 0.5 0.5
0.0016 0.5 0.5
0.0032 0.5 0.5
0.0093 0.8828 0.5
0.0063 1 1
0.0032 0.5 0.5
0.0039 0.5 0.5
0.0027 1 0.5
0.0012 0.5 0.5
0.0091 1 0.5
0.0064 0.3377 0.5
0.0022 0.5 0.5
0.0081 1 0.5
0.0033 1 1
0.0059 1 1
0.0056 1 0.5
0.0063 0.7244 0
0.0088 0.4477 1
0.0016 0.5 0.5
0.0037 1 0.5
0.0023 0.5 0.5
0.0042 0.5 0.5
0.0007 0.5 0.5
0.0029 0.5 0.5
0.0069 0.3067 0.5
0.0026 0.5 0.5
0.0066 0.3101 0.5
0.0018 0.5 0.5
0.0092 1 0.5
0.0004 0.5 0.5
0.0003 0.5 0.5
0.0011 1 0.5
0.0033 0.5 0.5
0.0012 0.5 0.5
0.0081 0.5 0.5
0.0062 0.6935 0.5
0.0061 0.6883 0.5304
0.0007 0.5 0.5
0.0059 1 1
0.0008 0.5 0.5
0.0007 0.5 0.5
0.0067 0.5 0.5
0.0036 0.5 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier TVAG_362360 (Trichomonas vaginalis), CMGC family protein kinase
Title for this comment
Comment